OWENS & MINOR INC/VA/ - Quarter Report: 2019 March (Form 10-Q)

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________________________________________

FORM 10-Q

________________________________________________



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-9810

_______________________________________________________

Owens & Minor, Inc.

(Exact name of Registrant as specified in its charter)

_______________________________________________________



Virginia	54-1701843
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

9120 Lockwood Boulevard, Mechanicsville, Virginia	23116
(Address of principal executive offices)	(Zip Code)

Post Office Box 27626, Richmond, Virginia	23261-7626
(Mailing address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code (804) 723-7000

_________________________________________________________

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “larger accelerated filer”, “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.



Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	o (Do not check if a smaller reporting company)	Smaller reporting company	¨
Emerging growth company	o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.			o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of Owens & Minor, Inc.’s common stock outstanding as of May 1, 2019, was 62,935,985 shares.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Index



Part I. Financial Information		Page

Item 1.	Financial Statements	3
	Consolidated Statements of Income (Loss) —Three Months Ended March 31, 2019 and 2018	3
	Consolidated Statements of Comprehensive Income (Loss) —Three Months Ended March 31, 2019 and 2018	4
	Consolidated Balance Sheets—March 31, 2019 and December 31, 2018	5
	Consolidated Statements of Cash Flows—Three Months Ended March 31, 2019 and 2018	6
	Consolidated Statements of Changes in Equity—Three Months Ended March 31, 2019 and 2018	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
Item 4.	Controls and Procedures	32
Part II. Other Information
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities	33
Item 6.	Exhibits	34

Table of Contents

Part I. Financial Information

Item 1. Financial Statements

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Income (Loss)

(unaudited)



	Three Months Ended March 31,
(in thousands, except per share data)	2019			2018
Net revenue	$	2,461,388		$	2,372,579
Cost of goods sold	2,102,964			2,047,892
Gross margin	358,424			324,687
Distribution, selling and administrative expenses	338,703			284,361
Acquisition-related and exit and realignment charges	4,990			14,760
Other operating expense, net	39			1,349
Operating income	14,692			24,217
Interest expense, net	29,101			10,253
Income (loss) before income taxes	(14,409		)	13,964
Income tax (benefit) provision	(313		)	5,813
Net income (loss)	$	(14,096	)	$	8,151

Net income (loss) per common share: basic and diluted	$	(0.23	)	$	0.13

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(unaudited)



	Three Months Ended March 31,
(in thousands)	2019			2018
Net income (loss)	$	(14,096	)	$	8,151
Other comprehensive income (loss), net of tax:
Currency translation adjustments (net of income tax of $0 in 2019 and 2018)	(4,207		)	8,921
Change in unrecognized net periodic pension costs (net of income tax of $69 in 2019 and $142 in 2018)	197			380
Net unrealized gain (loss) on derivative instruments and other (net of income tax of $658 in 2019 and $0 in 2018)	(2,413		)	6
Total other comprehensive income (loss), net of tax	(6,423		)	9,307
Comprehensive income (loss)	$	(20,519	)	$	17,458

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Balance Sheets

(unaudited)



	March 31,			December 31,
(in thousands, except per share data)	2019			2018
Assets
Current assets
Cash and cash equivalents	$	75,239		$	103,367
Accounts receivable, net of allowances of $21,572 and $19,618	843,384			823,418
Merchandise inventories	1,210,558			1,290,103
Other current assets	336,065			321,690
Total current assets	2,465,246			2,538,578
Property and equipment, net of accumulated depreciation of $283,804 and $270,105	386,135			386,723
Operating lease assets	197,200			—
Goodwill	413,235			414,122
Intangible assets, net	311,254			321,764
Other assets, net	109,294			112,601
Total assets	$	3,882,364		$	3,773,788
Liabilities and equity
Current liabilities
Accounts payable	$	990,688		$	1,109,589
Accrued payroll and related liabilities	40,999			48,203
Other current liabilities	377,989			314,219
Total current liabilities	1,409,676			1,472,011
Long-term debt, excluding current portion	1,685,135			1,650,582
Operating lease liabilities, excluding current portion	155,703			—
Deferred income taxes	42,144			50,852
Other liabilities	87,867			81,924
Total liabilities	3,380,525			3,255,369
Commitments and contingencies
Equity
Common stock, par value $2 per share; authorized - 200,000 shares; issued and outstanding - 62,936 shares and 62,294 shares	125,872			124,588
Paid-in capital	241,547			238,773
Retained earnings	186,455			200,670
Accumulated other comprehensive loss	(52,035		)	(45,612		)
Total equity	501,839			518,419
Total liabilities and equity	$	3,882,364		$	3,773,788

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(unaudited)



	Three Months Ended March 31,
(in thousands)	2019			2018
Operating activities:
Net income (loss)	$	(14,096	)	$	8,151
Adjustments to reconcile net income to cash (used for) provided by operating activities:
Depreciation and amortization	28,720			17,911
Share-based compensation expense	4,505			3,035
Provision for losses on accounts receivable	3,619			1,073
Deferred income tax benefit	(8,613		)	(1,482		)
Changes in operating assets and liabilities:
Accounts receivable	(22,573		)	(18,519		)
Merchandise inventories	80,194			(30,556		)
Accounts payable	(120,480		)	9,478
Net change in other assets and liabilities	(15,858		)	28,904
Other, net	3,678			278
Cash (used for) provided by operating activities	(60,904		)	18,273
Investing activities:
Additions to property and equipment	(11,674		)	(7,074		)
Additions to computer software and intangible assets	(2,605		)	(7,086		)
Proceeds from sale of property and equipment	271			—
Cash used for investing activities	(14,008		)	(14,160		)
Financing activities:
Borrowings (repayments) under revolving credit facility	72,100			(300		)
Repayments of debt	(12,394		)	(3,125		)
Financing costs paid	(4,313		)	—
Cash dividends paid	(4,764		)	(16,074		)
Other, net	(1,124		)	(2,304		)
Cash provided by (used for) financing activities	49,505			(21,803		)
Effect of exchange rate changes on cash and cash equivalents	(2,721		)	800
Net decrease in cash and cash equivalents	(28,128		)	(16,890		)
Cash and cash equivalents at beginning of period	103,367			104,522
Cash and cash equivalents at end of period	$	75,239		$	87,632
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	$	(12,388	)	$	1,197
Interest paid	$	24,504		$	9,661

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Changes in Equity

(unaudited)



(in thousands, except per share data)	Common Shares Outstanding	Common Stock ($2 par value )		Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Total Equity
Balance, December 31, 2017	61,476	$	122,952	$	226,937	$	690,674		$	(25,084	)	$	1,015,479
Net income						8,151						8,151
Other comprehensive income									9,307			9,307
Dividends declared ($0.26 per share)						(16,027		)				(16,027		)
Share-based compensation expense, exercises and other	336	672		1,336								2,008
Balance, March 31, 2018	61,812	$	123,624	$	228,273	$	682,798		$	(15,777	)	$	1,018,918

Balance, December 31, 2018	62,294	$	124,588	$	238,773	$	200,670		$	(45,612	)	$	518,419
Net loss						(14,096		)				(14,096		)
Other comprehensive loss									(6,423		)	(6,423		)
Dividends declared ($0.0025 per share)						(119		)				(119		)
Share-based compensation expense, exercises and other	642	1,284		2,774								4,058
Balance, March 31, 2019	62,936	$	125,872	$	241,547	$	186,455		$	(52,035	)	$	501,839

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(unaudited)

(in thousands, unless otherwise indicated)

Note 1—Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited consolidated financial statements include the accounts of Owens & Minor, Inc. and the subsidiaries it controls (we, us, or our) and contain all adjustments (which are comprised only of normal recurring accruals and use of estimates) necessary to conform with U.S. generally accepted accounting principles (GAAP). All significant intercompany accounts and transactions have been eliminated. The results of operations for interim periods are not necessarily indicative of the results expected for the full year.

Reclassifications

Certain prior year amounts have been reclassified to conform to current year presentation.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires us to make assumptions and estimates that affect reported amounts and related disclosures. Actual results may differ from these estimates.

See Note 15 for disaggregation of revenue by segment and geography as we believe that best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors.

Note 2—Fair Value

The carrying amounts of cash and cash equivalents, accounts receivable, financing receivables, accounts payable and financing payables included in the consolidated balance sheets approximate fair value due to the short-term nature of these instruments. The fair value of long-term debt is estimated based on quoted market prices or dealer quotes for the identical liability when traded as an asset in an active market (Level 1) or, if quoted market prices or dealer quotes are not available, on the borrowing rates currently available for loans with similar terms, credit ratings, and average remaining maturities (Level 2). The fair value of interest rate swaps and foreign currency contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows.

Note 3—Acquisitions

On April 30, 2018 (the Closing Date), we completed the acquisition of substantially all of Avanos Medical, Inc.'s (Avanos, previously Halyard Health, Inc.) Surgical and Infection Prevention (S&IP) business, the name “Halyard Health” (and all variations of that name and related intellectual property rights) and its information technology (IT) systems in exchange for $758 million, net of cash acquired. The Halyard business is a leading global provider of medical supplies and solutions for the prevention of healthcare associated infections across acute care and non-acute care markets. This business is reported as part of the Global Products segment.

The following table presents the preliminary estimated fair value of the assets acquired and liabilities assumed recognized as of the acquisition date. The fair value of intangibles from this acquisition was primarily determined by applying the income approach, using several significant unobservable inputs for projected cash flows and a discount rate. These inputs are considered Level 3 inputs. The allocation of purchase price to assets and liabilities acquired is not yet complete, as valuations of certain tangible and intangible assets are still in process.

Table of Contents



	Preliminary Fair Value Originally Estimated as of Acquisition Date ⁽¹⁾		Differences Between Prior and Current Period Preliminary Fair Value		Fair Value Estimated as of Acquisition Date
Assets acquired:
Current assets	$	330,870	$	—	$	330,870
Goodwill	130,364		—		130,364
Intangible assets	191,230		—		191,230
Other noncurrent assets	218,240		—		218,240
Total assets	870,704		—		870,704
Liabilities assumed:
Current liabilities	92,438		—		92,438
Noncurrent liabilities	20,217		—		20,217
Total liabilities	112,655		—		112,655
Fair value of net assets acquired, net of cash	$	758,049	$	—	$	758,049

⁽¹⁾As previously reported in our 2018 Form 10-K.

We are amortizing the preliminary fair value of acquired intangible assets, primarily customer relationships, a trade name and other intellectual property, over their estimated weighted average useful lives of eight to 12 years.

Goodwill of $130 million, which we assigned to our Global Products segment, consists largely of expected opportunities to expand into new markets and further develop a presence in the medical products segment. None of the goodwill recognized is expected to be deductible for income tax purposes.

The unaudited pro forma results of net revenue for the period ended March 31, 2018 as if Halyard was acquired on January 1, 2018 were $2,582,579. The pro forma results of net income (loss) and net income (loss) per common share have not been represented because the effects were not material to our historic consolidated financial statements. Accordingly, the pro forma results noted above are not necessarily indicative of the results that would have been if the acquisition had occurred on the dates indicated, nor are the pro forma results indicative of results which may occur in the future.

Note 4—Financing Receivables and Payables

At March 31, 2019 and December 31, 2018, we had financing receivables of $209.7 million and $183.3 million, respectively, and related payables of $100.5 million and $100.3 million, respectively, outstanding under our order-to-cash program, which were included in other current assets and other current liabilities, respectively, in the consolidated balance sheets.

Note 5—Goodwill and Intangible Assets

The following table summarizes the goodwill balances by segment and the changes in the carrying amount of goodwill through March 31, 2019:



	Global Solutions		Global Products			Consolidated
Carrying amount of goodwill, December 31, 2018	$	283,905	$	130,217		$	414,122
Currency translation adjustments	—		(887		)	(887		)
Carrying amount of goodwill, March 31, 2019	$	283,905	$	129,330		$	413,235

Table of Contents

Intangible assets at March 31, 2019 and December 31, 2018, were as follows:



	March 31, 2019									December 31, 2018
	Customer Relationships			Tradenames			Other Intangibles			Customer Relationships			Tradenames			Other Intangibles

Gross intangible assets	$	267,732		$	97,000		$	42,724		$	267,510		$	97,000		$	42,930
Accumulated amortization	(79,999		)	(10,779		)	(5,424		)	(72,947		)	(8,544		)	(4,185		)
Net intangible assets	$	187,733		$	86,221		$	37,300		$	194,563		$	88,456		$	38,745
Weighted average useful life	10 years			11 years			8 years			10 years			11 years			8 years

At March 31, 2019, $102.0 million in net intangible assets were held in the Global Solutions segment and $209.3 million were held in the Global Products segment. Amortization expense for intangible assets was $10.4 million and $6.4 million for the three months ended March 31, 2019 and 2018, respectively.

Based on the current carrying value of intangible assets subject to amortization, estimated amortization expense is $31.2 million for the remainder of 2019, $40.7 million for 2020, $39.0 million for 2021, $38.1 million for 2022, $36.9 million for 2023 and $31.6 million for 2024.

Note 6—Leases

We enter into non-cancelable agreements to lease most of our office and warehouse facilities with remaining terms generally ranging from one to 20 years. Certain leases include renewal options, generally for five-year increments. The exercise of lease renewal options is at our sole discretion. Our lease terms may include those options to extend or terminate the lease when it is reasonably certain that we will exercise that option. We also lease some of our transportation and material handling equipment for terms generally ranging from three to 10 years. Leases with a term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease asset also includes any lease payments made and excludes lease incentives.

The components of lease expense were as follows:



	Classification	Three months ended March 31, 2019
Operating lease cost ⁽¹⁾	Distribution, selling and administrative expenses	$	17,437
Finance lease cost:
Amortization of lease assets	Distribution, selling and administrative expenses	756
Interest on lease liabilities	Interest expense, net	334
Total finance lease cost		1,090
Total lease cost		$	18,527

⁽¹⁾ Includes short-term lease and variable lease costs, which are immaterial.

Table of Contents

Supplemental balance sheet information is as follows:



	Classification	As of March 31, 2019
Assets:
Operating lease assets	Operating lease assets	$	197,200
Finance lease assets	Property and equipment, net	10,921
Total lease assets		$	208,121
Liabilities:
Current
Operating	Other current liabilities	$	44,876
Finance	Other current liabilities	2,365
Noncurrent
Operating	Operating lease liabilities, excluding current portion	155,703
Finance	Long-term debt, excluding current portion	12,820
Total lease liabilities		$	215,764

Other information related to leases was as follows:



	Three months ended March 31, 2019
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating and finance leases	$	16,695
Financing cash flows from finance leases	$	674

Right-of-use assets obtained in exchange for new operating and finance lease liabilities	$	5,635

Weighted average remaining lease term (years)
Operating leases	6.3
Finance leases	8.3

Weighted average discount rate
Operating leases	12.3		%
Finance leases	8.9		%

Table of Contents

Maturities of lease liabilities as of March 31, 2019 were as follows:



	Operating Leases			Finance Leases			Total
2019 (remainder)	$	56,059		$	3,031		$	59,090
2020	57,703			2,824			60,527
2021	49,044			2,268			51,312
2022	30,612			2,073			32,685
2023	22,120			1,952			24,072
Thereafter	83,122			10,367			93,489
Total lease payments	298,660			22,515			321,175
Less: Interest	(98,081		)	(7,330		)	(105,411		)
Present value of lease liabilities	$	200,579		$	15,185		$	215,764

At December 31, 2018, future minimum annual payments under non-cancelable lease agreements with original terms in excess of one year, and including payments required under operating leases for facilities we have vacated, were as follows:



	Total
2019	$	64,082
2020	53,138
2021	42,480
2022	26,445
2023	19,895
Thereafter	45,708
Total minimum payments	$	251,748

Rent expense for all operating leases for the year ended December 31, 2018 was $78.3 million.

Note 7—Derivatives

We are directly and indirectly affected by changes in foreign currency, which may adversely impact our financial performance and are referred to as “market risks.” When deemed appropriate, we use derivatives as a risk management tool to mitigate the potential impact of certain market risks. We do not enter into derivative financial instruments for trading purposes.

We use a layered hedging program to hedge select anticipated foreign currency cash flows to reduce volatility in cash flows. We account for the designated foreign exchange forward contracts as cash flow hedges. These foreign exchange forward contracts generally have maturities up to 12 months and the counterparties to the transactions are typically large international financial institutions.

We pay interest under our Credit Agreement which fluctuates based on changes in our benchmark interest rates. In order to mitigate the risk of increases in benchmark rates, we entered into interest rate swaps during the third quarter of 2018 whereby we agree to exchange with the counterparty, at specified intervals, the difference between fixed and variable amounts calculated by reference to the notional amount. The interest rate swaps were designated as cash flow hedges. Cash flows related to the interest rate swap agreements are included in interest expense.

We determine the fair value of our foreign currency derivatives and our interest rate swaps based on observable market-based inputs or unobservable inputs that are corroborated by market data. We do not view the fair value of our derivatives in isolation, but rather in relation to the fair values or cash flows of the underlying exposure. Our derivatives are over-the-counter instruments with liquid markets. All derivatives are carried at fair value in our consolidated balance sheets in other assets and other liabilities. We consider the risk of counterparty default to be minimal. We report cash flows from our hedging instruments in the same cash flow statement category as the hedged items.

We enter into foreign currency contracts to manage our foreign exchange exposure related to certain balance sheet items that do not meet the requirements for hedge accounting. These derivative instruments are adjusted to fair value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. We record the change in fair value of derivative instruments and the remeasurement adjustment on the foreign currency denominated asset or liability in acquisition-related and exit and realignment charges for contracts assumed with the Halyard acquisition and in other operating expense, net for all other foreign exchange contracts.

Table of Contents

The following table summarizes the terms and fair value of our outstanding derivative financial instruments as of March 31, 2019:



				Derivative Assets			Derivative Liabilities
	Notional Amount		Maturity Date	Classification	Fair Value		Classification	Fair Value
Cash flow hedges
Interest rate swaps	$	450,000	May 2022 and 2025	Other assets, net	$	—	Other liabilities	$	10,969
Foreign currency contracts	$	13,448	June 2019 to December 2019	Other assets, net	$	317	Other liabilities	$	—

Economic (non-designated) hedges
Foreign currency contracts	$	10,610	April 2019 to May 2019	Other assets, net	$	229	Other liabilities	$	13

The following table summarizes the effect of cash flow hedge accounting on our consolidated statement of income for the period ended March 31, 2019:



	Amount of Gain/(Loss) Recognized in Other Comprehensive Income (Loss)			Location of Gain/(Loss) Reclassified from Accumulated Other Comprehensive Income into Income	Total Amount of Income/(Expense) Line Items Presented in the Consolidated Statement of Income in Which the Effects are Recorded			Amount of Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Income
Interest rate swaps	$	(4,094	)	Interest expense, net	$	(29,101	)	$	(321	)
Foreign currency contracts	$	445		Cost of goods sold	$	(2,102,964	)	$	(257	)

The amount of ineffectiveness associated with these contracts was immaterial for the periods presented.

For the period ended March 31, 2019, we recognized a gain of $0.5 million associated with our economic (non-designated) foreign currency contracts.

We were not a party to any derivatives for the period ended March 31, 2018.

Note 8—Exit and Realignment Costs

We periodically incur exit and realignment and other charges associated with optimizing our operations which includes the consolidation of certain distribution and logistics centers, administrative offices and warehouses in the United States and Europe. These charges also include costs associated with our strategic organizational realignment which include management changes, certain professional fees, and costs to streamline administrative functions and processes.

Exit and realignment charges by segment for the three months ended March 31, 2019 and 2018 were as follows:



	Three Months Ended March 31,
	2019		2018
Global Solutions segment	$	824	$	2,708
Global Products segment	7		(29		)
Total exit and realignment charges	$	831	$	2,679

Table of Contents

The following table summarizes the activity related to exit and realignment cost and related accruals through March 31, 2019 and 2018:



	Total ⁽¹⁾
Accrued exit and realignment costs, December 31, 2018	$	8,214
Provision for exit and realignment activities:
Severance	360
Information system restructuring costs	515
Other	83
Change in estimate	(127		)
Cash payments	(3,079		)
Accrued exit and realignment costs, March 31, 2019	$	5,966


Accrued exit and realignment costs, December 31, 2017	$	11,972
Provision for exit and realignment activities:
Severance	2,295
Information system restructuring costs	177
Other	230
Change in estimate	(23		)
Cash payments	(6,886		)
Accrued exit and realignment costs, March 31, 2018	$	7,765

⁽¹⁾The accrued exit and realignment costs at March 31, 2019 and 2018 related primarily to accrued information system restructuring costs and accrued severance.

Note 9—Retirement Plans

We have a noncontributory, unfunded retirement plan for certain officers and retirees in the United States. Certain of our foreign subsidiaries also have defined benefit pension plans covering substantially all of their respective employees.

The components of net periodic benefit cost, which are included in distribution, selling and administrative expenses, for the three months ended March 31, 2019 and 2018, were as follows:



	Three Months Ended March 31,
	2019		2018
Service cost	$	374	$	19
Interest cost	600		419
Recognized net actuarial loss	260		522
Net periodic benefit cost	$	1,234	$	960

Certain of our foreign subsidiaries have health and welfare plans covering substantially all of their respective employees. Our expense for these plans totaled $0.6 million and $0.5 million for the three months ended March 31, 2019 and 2018, respectively.

Note 10—Debt

Debt consists of the following:

Table of Contents



	March 31, 2019						December 31, 2018
	Carrying Amount			Estimated Fair Value			Carrying Amount			Estimated Fair Value
3.875% Senior Notes, $275 million par value, due September 2021	$	273,684		$	219,307		$	273,577		$	207,001
4.375% Senior Notes, $275 million par value, due December 2024	273,079			177,298			272,972			174,859
Term A Loans, due July 2022	409,212			409,212			422,422			422,422
Term B Loan, due April 2025	482,201			388,050			483,327			385,284
Revolver	282,200			282,200			210,100			210,100
Finance leases and other	16,777			16,777			18,774			18,774
Total debt	1,737,153			1,492,844			1,681,172			1,418,440
Less current maturities	(52,018		)	(52,018		)	(30,590		)	(30,590		)
Long-term debt	$	1,685,135		$	1,440,826		$	1,650,582		$	1,387,850

We have a Credit Agreement (amended February 2019) with a borrowing capacity of $400 million and term loans. The interest rate on our revolving credit facility and Term A loans is based on the Eurocurrency Rate, the Federal Funds Rate or the Prime Rate, plus an adjustment based on our Consolidated Total Leverage Ratio as defined by the Credit Agreement. Our Term B loan accrues interest based on the Eurocurrency Rate, the Federal Funds Rate or the Prime Rate, plus interest rate margin of 3.50% per annum with respect to Base Rate Loans (as defined in the Credit Agreement), and 4.50% per annum with respect to Eurocurrency Rate Loans (as defined in the Credit Agreement). We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Credit Agreement requires us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. Our credit spread at March 31, 2019 was Eurocurrency Rate plus 3.5%.

We also have a Security and Pledge Agreement (the Security Agreement) pursuant to which we granted collateral on behalf of the holders of the 2021 Notes and the 2024 Notes and parties secured on the Credit Agreement (the Secured Parties) including first priority liens and security interests in (a) all present and future shares of capital stock owned by the Credit Parties (as defined) in the Credit Parties’ present and future subsidiaries (limited, in the case of controlled foreign corporations, to a pledge of 65% of the voting capital stock of each first-tier foreign subsidiary of each Credit Party) and (b) all present and future personal property and assets of the Credit Parties, subject to certain exceptions. Our Credit Agreement has a “springing maturity date” with respect to the revolving loans and the Term A loans and the Term B loan, if as of the date that is 91 days prior to the maturity date of the Company’s 2021 Notes or the 2024 Notes, respectively, all outstanding amounts owing under the 2021 Notes or the 2024 Notes, respectively, have not been paid in full then the Termination Date (as defined in the Credit Agreement) of the revolving credit facility, Term A loans and Term B loan shall be the date that is 91 days prior to the maturity date of the 2021 Notes.

At March 31, 2019, we had letters of credit of $11.7 million outstanding under the Credit Agreement. We also had letters of credit and bank guarantees outstanding for $7.7 million as of March 31, 2019 and December 31, 2018, respectively, which supports certain facilities leased as well as other normal business activities in the United States and Europe.

The Credit Agreement and senior notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of either agreement. We believe we were in compliance with our debt covenants at March 31, 2019.

As of March 31, 2019, scheduled future principal payments of debt were $37.2 million in 2019, $49.6 million in 2020, $324.7 million in 2021, $581.0 million in 2022, $5.0 million in 2023, and $748.8 million thereafter.

Note 11—Income Taxes

The effective tax rate was 2.2% for the three months ended March 31, 2019, compared to 41.6% in the same quarter of 2018. The decrease in the rate resulted from the mixture of income and losses in jurisdictions in which the company operates, including those of which require a full valuation allowance, and the incremental income tax expense associated with the vesting of restricted stock. The liability for unrecognized tax benefits was $11.2 million at March 31, 2019 and $9.6 million at December 31, 2018. Included in the liability at March 31, 2019 were $3.3 million of tax positions for which ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.

Table of Contents

Note 12—Net Income per Common Share

The following summarizes the calculation of net income per common share attributable to common shareholders for the three months ended March 31, 2019 and 2018:



	Three Months Ended March 31,
(in thousands, except per share data)	2019			2018
Numerator:
Net income (loss)	$	(14,096	)	$	8,151
Less: income allocated to unvested restricted shares	—			(323		)
Net income (loss) attributable to common shareholders - basic and diluted	$	(14,096	)	$	7,828
Denominator:
Weighted average shares outstanding - basic and diluted	60,376			59,969
Net income (loss) per share attributable to common shareholders:
Basic and diluted	$	(0.23	)	$	0.13

Note 13—Shareholders’ Equity

Our Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a 3-year period, expiring in December 2019. The timing of repurchases and the exact number of shares of common stock to be purchased will depend upon market conditions and other factors and may be suspended or discontinued at any time. Purchases under the share repurchase program are made either pursuant to 10b5-1 plans entered into by the company from time to time and/or during the company’s scheduled quarterly trading windows for officers and directors. Our Credit Agreement contains restrictions on the amount and timing of share repurchase activity. This includes prohibiting share repurchases should a default under the Credit Agreement exist prior to or immediately after any share repurchases. We did not repurchase any shares of our common stock during the quarters ended March 31, 2019 and 2018. As of March 31, 2019, we have approximately $94.0 million in remaining authorization available under the repurchase program. We have elected to allocate any excess of share repurchase price over par value to retained earnings.

Table of Contents

Note 14—Accumulated Other Comprehensive Income (Loss)

The following table shows the changes in accumulated other comprehensive income (loss) by component for the three months ended March 31, 2019 and 2018:



	Retirement Plans			Currency Translation Adjustments			Derivatives and Other			Total
Accumulated other comprehensive income (loss), December 31, 2018	$	(8,146	)	$	(32,551	)	$	(4,915	)	$	(45,612	)
Other comprehensive income (loss) before reclassifications	—			(4,207		)	(3,649		)	(7,856		)
Income tax	—			—			808			808
Other comprehensive income (loss) before reclassifications, net of tax	—			(4,207		)	(2,841		)	(7,048		)
Amounts reclassified from accumulated other comprehensive income (loss)	266			—			578			844
Income tax	(69		)	—			(150		)	(219		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	197			—			428			625
Other comprehensive income (loss)	197			(4,207		)	(2,413		)	(6,423		)
Accumulated other comprehensive income (loss), March 31, 2019	$	(7,949	)	$	(36,758	)	$	(7,328	)	$	(52,035	)



	Retirement Plans			Currency Translation Adjustments			Derivatives and Other		Total
Accumulated other comprehensive income (loss), December 31, 2017	$	(12,066	)	$	(13,185	)	$	167	$	(25,084	)
Other comprehensive income (loss) before reclassifications	—			8,921			6		8,927
Income tax	—			—			—		—
Other comprehensive income (loss) before reclassifications, net of tax	—			8,921			6		8,927
Amounts reclassified from accumulated other comprehensive income (loss)	522			—					522
Income tax	(142		)	—			—		(142		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	380			—			—		380
Other comprehensive income (loss)	380			8,921			6		9,307
Accumulated other comprehensive income (loss), March 31, 2018	$	(11,686	)	$	(4,264	)	$	173	$	(15,777	)

We include amounts reclassified out of accumulated other comprehensive income (loss) related to defined benefit pension plans as a component of net periodic pension cost recorded in distribution, selling and administrative expenses. For the three months ended March 31, 2019 and 2018, we reclassified $0.3 million and $0.5 million, respectively, of actuarial net losses.

Note 15—Segment Information

We periodically evaluate our application of accounting guidance for reportable segments and disclose information about reportable segments based on the way management organizes the enterprise for making operating decisions and assessing performance. We report our business under two segments: Global Solutions and Global Products. The Global Solutions segment includes our United States and European distribution, logistics and value-added services business. Global Products manufactures and sources medical surgical products through our production and kitting operations. The Halyard business, acquired on April 30, 2018, is part of Global Products.

We evaluate the performance of our segments based on their operating income excluding intangible amortization, acquisition-related and exit and realignment charges, certain purchase price fair value adjustments, and other substantive items

Table of Contents

that, either as a result of their nature or size, would not be expected to occur as part of our normal business operations on a regular basis.

Segment assets exclude inter-segment account balances as we believe their inclusion would be misleading and not meaningful. We believe all inter-segment sales are at prices that approximate market.

The following tables present financial information by segment:



	Three Months Ended March 31,
	2019			2018
Net revenue:
Segment net revenue
Global Solutions	$	2,234,147		$	2,341,122
Global Products	347,085			121,287
Total segment net revenue	2,581,232			2,462,409
Inter-segment revenue
Global Products	(119,844		)	(89,830		)
Total inter-segment revenue	(119,844		)	(89,830		)
Consolidated net revenue	$	2,461,388		$	2,372,579

Operating income (loss):
Global Solutions	$	21,071		$	36,759
Global Products	7,724			11,084
Inter-segment eliminations	1,747			(242		)
Intangible amortization	(10,361		)	(6,407		)
Acquisition-related and exit and realignment charges	(4,990		)	(14,760		)
Other ⁽¹⁾	(499		)	(2,217		)
Consolidated operating income	$	14,692		$	24,217

Depreciation and amortization:
Global Solutions	$	16,113		$	15,781
Global Products	12,607			2,130
Consolidated depreciation and amortization	$	28,720		$	17,911

Capital expenditures:
Global Solutions	$	11,376		$	13,602
Global Products	2,903			558
Consolidated capital expenditures	$	14,279		$	14,160

⁽¹⁾Other consists of Software as a Service (SaaS) implementation costs associated with significant global IT platforms in connection with the redesign of our global information system strategy.

Table of Contents



	March 31, 2019		December 31, 2018
Total assets:
Global Solutions	$	2,673,148	$	2,618,759
Global Products	1,133,977		1,051,662
Segment assets	3,807,125		3,670,421
Cash and cash equivalents	75,239		103,367
Consolidated total assets	$	3,882,364	$	3,773,788

The following table presents net revenue by geographic area, which were attributed based on the location from which we ship products or provide services.



	Three Months Ended March 31,
	2019		2018
Net revenue:
United States	$	2,303,913	$	2,252,634
International	157,475		119,945
Consolidated net revenue	$	2,461,388	$	2,372,579

Note 16—Condensed Consolidating Financial Information

The following tables present condensed consolidating financial information for: Owens & Minor, Inc. (O&M); the guarantors of Owens & Minor, Inc.’s 2021 Notes and 2024 Notes, on a combined basis; and the non-guarantor subsidiaries of the 2021 Notes and 2024 Notes, on a combined basis. The guarantor subsidiaries are 100% owned by Owens & Minor, Inc. Separate financial statements of the guarantor subsidiaries are not presented because the guarantees by our guarantor subsidiaries are full and unconditional, as well as joint and several, and we believe the condensed consolidating financial information is more meaningful in understanding the financial position, results of operations and cash flows of the guarantor subsidiaries. The prior period has been recasted for the change in guarantor structure as a result of the amended Credit Agreement.



Three Months Ended March 31, 2019	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	2,371,809		$	337,876		$	(248,297	)	$	2,461,388
Cost of goods sold	—			2,101,290			251,419			(249,745		)	2,102,964
Gross margin	—			270,519			86,457			1,448			358,424
Distribution, selling and administrative expenses	—			231,591			107,112			—			338,703
Acquisition-related and exit and realignment charges	—			4,721			269			—			4,990
Other operating expense, net	—			(426		)	465			—			39
Operating income	—			34,633			(21,389		)	1,448			14,692
Interest expense, net	7,488			18,467			3,146			—			29,101
Income (loss) before income taxes	(7,488		)	16,166			(24,535		)	1,448			(14,409		)
Income tax (benefit) provision	(771		)	(816		)	1,274			—			(313		)
Equity in earnings of subsidiaries	(7,379		)	(957		)	—			8,336			—
Net income (loss)	(14,096		)	16,025			(25,809		)	9,784			(14,096		)
Other comprehensive income (loss)	(6,423		)	(3,393		)	(4,157		)	7,550			(6,423		)
Comprehensive income (loss)	$	(20,519	)	$	12,632		$	(29,966	)	$	17,334		$	(20,519	)

Table of Contents



Three Months Ended March 31, 2018	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	2,228,490		$	183,637		$	(39,548	)	$	2,372,579
Cost of goods sold	—			1,994,151			93,212			(39,471		)	2,047,892
Gross margin	—			234,339			90,425			(77		)	324,687
Distribution, selling and administrative expenses	(179		)	196,369			88,171			—			284,361
Acquisition-related and exit and realignment charges	—			13,815			945			—			14,760
Other operating expense, net	—			(583		)	1,932			—			1,349
Operating income	179			24,738			(623		)	(77		)	24,217
Interest expense, net	6,741			1,991			1,521			—			10,253
Income (loss) before income taxes	(6,562		)	22,747			(2,144		)	(77		)	13,964
Income tax (benefit) provision	—			4,456			1,357			—			5,813
Equity in earnings of subsidiaries	14,713			150			—			(14,863		)	—
Net income (loss)	8,151			18,441			(3,501		)	(14,940		)	8,151
Other comprehensive income (loss)	9,307			9,363			8,921			(18,284		)	9,307
Comprehensive income (loss)	$	17,458		$	27,804		$	5,420		$	(33,224	)	$	17,458

Table of Contents



March 31, 2019	Owens & Minor, Inc.			Guarantor Subsidiaries			Non- guarantor Subsidiaries			Eliminations			Consolidated
March 31, 2019	Owens & Minor, Inc.			Guarantor Subsidiaries			Non- guarantor Subsidiaries			Eliminations			Consolidated
Balance Sheets
Assets
Current assets
Cash and cash equivalents	$	5,971		$	43,611		$	25,657		$	—		$	75,239
Accounts receivable, net	—			887,822			598,948			(643,386		)	843,384
Merchandise inventories	—			980,441			233,425			(3,308		)	1,210,558
Other current assets	29			99,190			236,846			—			336,065
Total current assets	6,000			2,011,064			1,094,876			(646,694		)	2,465,246
Property and equipment, net	—			197,088			189,047			—			386,135
Operating lease assets	2,768			128,775			65,657			—			197,200
Goodwill	—			413,235			—			—			413,235
Intangible assets, net	—			269,143			42,111			—			311,254
Due from O&M and subsidiaries	—			988,509			—			(988,509		)	—
Advances to and investment in consolidated subsidiaries	1,689,812			88,164			—			(1,777,976		)	—
Other assets, net	—			52,910			56,384			—			109,294
Total assets	$	1,698,580		$	4,148,888		$	1,448,075		$	(3,413,179	)	$	3,882,364
Liabilities and equity
Current liabilities
Accounts payable	$	—		$	1,233,448		$	411,353		$	(654,113	)	$	990,688
Accrued payroll and related liabilities	—			20,714			20,285			—			40,999
Other current liabilities	5,488			222,202			150,299			—			377,989
Total current liabilities	5,488			1,476,364			581,937			(654,113		)	1,409,676
Long-term debt, excluding current portion	626,771			1,044,342			14,022			—			1,685,135
Operating lease liabilities, excluding current portion	1,661			108,810			45,232			—			155,703
Due to O&M and subsidiaries	552,974			—			683,403			(1,236,377		)	—
Intercompany debt	—			1,246,785			322,105			(1,568,890		)	—
Deferred income taxes	—			16,829			25,315			—			42,144
Other liabilities	9,847			58,994			19,026			—			87,867
Total liabilities	1,196,741			3,952,124			1,691,040			(3,459,380		)	3,380,525
Equity
Common stock	125,872			—			—			—			125,872
Paid-in capital	241,547			174,614			123,865			(298,479		)	241,547
Retained earnings (deficit)	186,455			53,802			(345,445		)	291,643			186,455
Accumulated other comprehensive income (loss)	(52,035		)	(31,652		)	(21,385		)	53,037			(52,035		)
Total equity	501,839			196,764			(242,965		)	46,201			501,839
Total liabilities and equity	$	1,698,580		$	4,148,888		$	1,448,075		$	(3,413,179	)	$	3,882,364

Table of Contents



December 31, 2018	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Balance Sheets
Assets
Current assets
Cash and cash equivalents	$	37,254		$	5,294		$	60,819		$	—		$	103,367
Accounts receivable, net	—			804,638			482,675			(463,895		)	823,418
Merchandise inventories	—			1,060,083			234,778			(4,758		)	1,290,103
Other current assets	117			117,163			205,678			(1,268		)	321,690
Total current assets	37,371			1,987,178			983,950			(469,921		)	2,538,578
Property and equipment, net	—			201,055			185,668			—			386,723
Goodwill	—			414,122			—			—			414,122
Intangible assets, net	—			290,814			30,950			—			321,764
Due from O&M and subsidiaries	—			880,901			—			(880,901		)	—
Advances to and investments in consolidated subsidiaries	1,697,191			93,278			—			(1,790,469		)	—
Other assets, net	1,788			56,221			54,592			—			112,601
Total assets	$	1,736,350		$	3,923,569		$	1,255,160		$	(3,141,291	)	$	3,773,788
Liabilities and equity
Current liabilities
Accounts payable	$	—		$	1,190,283		$	394,664		$	(475,358	)	$	1,109,589
Accrued payroll and related liabilities	—			23,071			25,132			—			48,203
Other current liabilities	9,641			161,371			143,207			—			314,219
Total current liabilities	9,641			1,374,725			563,003			(475,358		)	1,472,011
Long-term debt, excluding current portion	595,856			1,040,664			14,062			—			1,650,582
Due to O&M and subsidiaries	605,558			—			67,900			(673,458		)	—
Intercompany debt	—			1,246,787			322,101			(1,568,888		)	—
Deferred income taxes	—			29,288			21,564			—			50,852
Other liabilities	6,876			51,366			23,682			—			81,924
Total liabilities	1,217,931			3,742,830			1,012,312			(2,717,704		)	3,255,369
Equity
Common stock	124,588			—			—			—			124,588
Paid-in capital	238,773			174,614			583,869			(758,483		)	238,773
Retained earnings (deficit)	200,670			37,777			(319,636		)	281,859			200,670
Accumulated other comprehensive income (loss)	(45,612		)	(31,652		)	(21,385		)	53,037			(45,612		)
Total equity	518,419			$	180,739		242,848			(423,587		)	518,419
Total liabilities and equity	$	1,736,350		$	3,923,569		$	1,255,160		$	(3,141,291	)	$	3,773,788

Table of Contents



Three Months Ended March 31, 2019	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated

Statements of Cash Flows
Operating activities:
Net income (loss)	$	(14,096	)	$	16,025		$	(25,809	)	$	9,784		$	(14,096	)
Adjustments to reconcile net income to cash provided by (used for) operating activities:
Equity in earnings of subsidiaries	7,379			957			—			(8,336		)	—
Depreciation and amortization	—			16,339			12,381			—			28,720
Share-based compensation expense	—			4,505			—			—			4,505
Provision for losses on accounts receivable	—			3,644			(25		)	—			3,619
Deferred income tax expense (benefit)	—			(4,851		)	(3,762		)	—			(8,613		)
Changes in operating assets and liabilities:
Accounts receivable	—			(86,828		)	(115,237		)	179,492			(22,573		)
Merchandise inventories	—			79,642			2,001			(1,449		)	80,194
Accounts payable	—			43,165			15,105			(178,750		)	(120,480		)
Net change in other assets and liabilities	(2,276		)	56,354			(69,195		)	(741		)	(15,858		)
Other, net	213			3,483			(18		)	—			3,678
Cash (used for) provided by operating activities	(8,780		)	132,435			(184,559		)	—			(60,904		)
Investing activities:
Additions to property and equipment	—			(3,666		)	(8,008		)	—			(11,674		)
Additions to computer software and intangible assets	—			(2,124		)	(481		)	—			(2,605		)
Proceeds from sale of property and equipment	—			—			271			—			271
Cash used for investing activities	—			(5,790		)	(8,218		)	—			(14,008		)
Financing activities:
Borrowing (repayments) under revolving credit facility	—			72,100			—			—			72,100
Repayment of debt	—			(12,394		)	—			—			(12,394		)
Financing costs paid	—			(4,313		)	—			—			(4,313		)
Change in intercompany advances	(17,292		)	(143,485		)	160,777			—			—
Cash dividends paid	(4,764		)	—			—			—			(4,764		)
Other, net	(447		)	(236		)	(441		)	—			(1,124		)
Cash provided by (used for) financing activities	(22,503		)	(88,328		)	160,336			—			49,505
Effect of exchange rate changes on cash and cash equivalents	—			—			(2,721		)	—			(2,721		)
Net increase (decrease) in cash and cash equivalents	(31,283		)	38,317			(35,162		)	—			(28,128		)
Cash and cash equivalents at beginning of period	37,254			5,294			60,819			—			103,367
Cash and cash equivalents at end of period	$	5,971		$	43,611		$	25,657		$	—		$	75,239

Table of Contents



Three Months Ended March 31, 2018	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated

Statements of Cash Flows
Operating activities:
Net income (loss)	$	8,151		$	18,441		$	(3,501	)	$	(14,940	)	$	8,151
Adjustments to reconcile net income to cash provided by (used for) operating activities:
Equity in earnings of subsidiaries	(14,713		)	(150		)	—			14,863			—
Depreciation and amortization	—			11,207			6,704			—			17,911
Share-based compensation expense	—			3,035			—			—			3,035
Provision for losses on accounts receivable	—			1,219			(146		)	—			1,073
Deferred income tax expense (benefit)	—			(1,453		)	(29		)	—			(1,482		)
Changes in operating assets and liabilities:
Accounts receivable	—			(60,302		)	41,636			147			(18,519		)
Merchandise inventories	—			(29,606		)	(1,026		)	76			(30,556		)
Accounts payable	—			13,696			(4,078		)	(140		)	9,478
Net change in other assets and liabilities	121			31,976			(3,187		)	(6		)	28,904
Other, net	250			132			(104		)	—			278
Cash (used for) provided by operating activities	(6,191		)	(11,805		)	36,269			—			18,273
Investing activities:
Additions to property and equipment	—			(5,847		)	(1,227		)	—			(7,074		)
Additions to computer software and intangible assets	—			(6,078		)	(1,008		)	—			(7,086		)
Cash used for investing activities	—			(11,925		)	(2,235		)	—			(14,160		)
Financing activities:
Borrowings (repayments) under revolving credit facility	—			(300		)	—			—			(300		)
Repayment of debt	—			(3,125		)	—			—			(3,125		)
Change in intercompany advances	22,949			22,151			(45,100		)	—			—
Cash dividends paid	(16,074		)	—			—			—			(16,074		)
Other, net	(1,113		)	(421		)	(770		)	—			(2,304		)
Cash provided by (used for) financing activities	5,762			18,305			(45,870		)	—			(21,803		)
Effect of exchange rate changes on cash and cash equivalents	—			—			800			—			800
Net increase (decrease) in cash and cash equivalents	(429		)	(5,425		)	(11,036		)	—			(16,890		)
Cash and cash equivalents at beginning of period	13,700			11,080			79,742			—			104,522
Cash and cash equivalents at end of period	$	13,271		$	5,655		$	68,706		$	—		$	87,632

Note 17—Recent Accounting Pronouncements

In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. ASU No. 2017-12 is intended to simplify the application of hedge accounting and provide increased transparency as to the scope and results of hedging programs. For calendar year-end entities, the update will be effective for annual periods beginning January 1, 2019, and interim periods within those fiscal years. The Company adopted ASU No. 2017-12 effective beginning January 1, 2019. Its adoption did not have a material impact on our consolidated financial statements.

Table of Contents

On February 14, 2018, the FASB issued ASU No. 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. ASU No. 2018-02 allows companies to reclassify stranded tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive income (loss) to retained earnings. ASU No. 2018-02 was effective for the Company on January 1, 2019 and we elected not to reclassify income tax effects due to the Act from accumulated other comprehensive income (loss) to retained earnings on the consolidated balance sheets in the period of adoption.

We adopted ASU No. 2016-02, Leases (Topic 842), as of January 1, 2019. We elected to use the adoption date as our date of initial application and thus have not restated comparative prior periods. We elected the ‘package of practical expedients’, which permits us not to reassess our prior conclusions about lease identification, lease classification and initial direct costs under the new standard. We did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.

The new standard also provides practical expedients for an entity’s ongoing accounting. We elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize right-of-use assets or lease liabilities, and this includes not recognizing right-of-use assets or lease liabilities for existing short-term leases of those assets in transition. We also elected the practical expedient to not separate lease and non-lease components for all of our leases.

The adoption of the new standard resulted in the recording of operating lease assets and lease liabilities of approximately $197 million and $201 million, respectively, as of January 1, 2019. The standard did not materially impact our consolidated net income and had no impact on cash flows.

There have been no further changes in our significant accounting policies from those contained in our Annual Report on Form 10-K for the year ended December 31, 2018.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis describes results of operations and material changes in the financial condition of Owens & Minor, Inc. and its subsidiaries since December 31, 2018. Trends of a material nature are discussed to the extent known and considered relevant. This discussion should be read in conjunction with the consolidated financial statements, related notes thereto, and management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the year ended December 31, 2018.

Overview

Owens & Minor, Inc., along with its subsidiaries, (we, us, or our) is a leading global healthcare solutions company with integrated technologies, products and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care.

On April 30, 2018 (the Closing Date), we acquired substantially all of Avanos Medical, Inc.'s (Avanos, previously Halyard Health, Inc.) Surgical and Infection Prevention business, the name “Halyard Health” (and all variations of that name and related intellectual property rights) and its information technology (IT) systems in exchange for $758 million, net of cash acquired. The Halyard business is a leading global provider of medical supplies and solutions for the prevention of healthcare associated infections across acute care and non-acute care markets. This business is reported as part of the Global Products segment.

We entered into transition services agreements with Avanos pursuant to which they and we will provide to each other various transitional services, including, but not limited to, facilities, product supply, financial and business services, procurement, human resources, research and development, regulatory affairs and quality assurance, sales and marketing, information technology and other support services. On the Closing Date, certain of our affiliates also entered into transitional distribution agreements with affiliates of Avanos under which the Avanos affiliates will serve as limited risk distributors for our international customer orders on a transitional basis. The services under the transition services agreements and distribution agreements generally commenced on the Closing Date and terminate within 18 months thereafter.

Table of Contents

Financial highlights. The following table provides a reconciliation of reported operating income, net income and net income per diluted common share to non-GAAP measures used by management.



	Three Months Ended March 31,
(Dollars in thousands except per share data)	2019			2018
Operating income, as reported (GAAP)	$	14,692		$	24,217
Intangible amortization ⁽¹⁾	10,361			6,407
Acquisition-related and exit and realignment charges⁽²⁾	4,990			14,760
Other ⁽³⁾	499			2,217
Operating income, adjusted (non-GAAP) (Adjusted Operated Income)	$	30,542		$	47,601
Operating Income as a percent of revenue (GAAP)	0.60		%	1.02		%
Adjusted Operating Income as a percent of revenue (non-GAAP)	1.24		%	2.01		%

Net income (loss), as reported (GAAP)	$	(14,096	)	$	8,151
Intangible amortization ⁽¹⁾	10,361			6,407
Income tax expense (benefit) ⁽⁵⁾	(1,664		)	(1,557		)
Acquisition-related and exit and realignment charges ⁽²⁾	4,990			14,760
Income tax expense (benefit) ⁽⁵⁾	(760		)	(3,576		)
Write-off of deferred financing costs ⁽⁴⁾	2,003			—
Income tax expense (benefit) ⁽⁵⁾	(313		)	—
Other ⁽³⁾	499			2,217
Income tax expense (benefit) ⁽⁵⁾	(55		)	(228		)
Net income, adjusted (non-GAAP) (Adjusted Net Income)	$	965		$	26,174

Net income (loss) per diluted common share, as reported (GAAP)	$	(0.23	)	$	0.13
Intangible amortization ⁽¹⁾	0.14			0.08
Acquisition-related and exit and realignment charges ⁽²⁾	0.07			0.19
Write-off of deferred financing costs ⁽⁴⁾	0.03			—
Other ⁽³⁾	0.01			0.03
Net income per diluted common share, adjusted (non-GAAP)(Adjusted EPS)	$	0.02		$	0.43

Net income (loss) per diluted share was $(0.23) for the three months ended March 31, 2019, a decline of $0.36 compared to 2018. Adjusted EPS (non-GAAP) was $0.02 in the first quarter of 2019, a decline of $0.41 when compared to prior year. Global Solutions segment operating income of $21.1 million declined $15.7 million from the first quarter of 2018 as a result of lower revenues, continued pressure on distribution margins, and higher supply chain costs. Global Products operating income, which includes Halyard, was $7.7 million in the first quarter of 2019 and $11.1 million in the first quarter of 2018.

Use of Non-GAAP Measures

Adjusted operating income, adjusted net income and adjusted EPS are an alternative view of performance used by management, and we believe that investors' understanding of our performance is enhanced by disclosing these performance measures. In general, the measures exclude items and charges that (i) management does not believe reflect our core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate our performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results and in comparing our performance to that of our competitors. However, the non-GAAP financial measures used by us may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by us should not be considered substitutes for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.

Table of Contents

The following items have been excluded in our non-GAAP financial measures:

⁽¹⁾Intangible amortization includes amortization of intangible assets established during purchase accounting for business combinations. These amounts are highly dependent on the size and frequency of acquisitions and are being excluded to allow for a more consistent comparison with forecasted, current and historical results and the results of our peers.

⁽²⁾ Acquisition-related charges were $4.2 million and $12.1 million in the first quarter of 2019 and 2018, respectively. Acquisition-related charges in 2019 and 2018 consist primarily of transition and transaction costs for the Halyard transaction.

Exit and realignment charges were $0.8 million in the first quarter of 2019 and $2.7 million in the first quarter of 2018. Amounts in 2019 were associated with the establishment of our client engagement centers and IT restructuring charges. Amounts in 2018 were associated with the establishment of our client engagement centers.

⁽³⁾ Other consists of Software as a Service (SaaS) implementation costs associated with significant global IT platforms in connection with the redesign of our global information system strategy.

⁽⁴⁾Write-off of deferred financing costs associated with the revolving credit facility as a result of the Fourth Amendment to the Credit Agreement.

⁽⁵⁾These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes.

Results of Operations

Net revenue.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2019			2018			$			%
Global Solutions	$	2,234,147		$	2,341,122		$	(106,975	)	(4.6	)%
Global Products	347,085			121,287			225,798			186.2	%
Inter-segment	(119,844		)	(89,830		)	(30,014		)	(33.4	)%
Net revenue	$	2,461,388		$	2,372,579		$	88,809		3.7	%

Consolidated net revenue increased primarily as a result of the acquisition of Halyard in April 2018, which contributed revenue of $188.7 million (net of intercompany eliminations) in the quarter. Lower distribution revenues as a result of customer non-renewals, primarily resulting from service issues, contributed to the year over year change in the Global Solutions segment, which was partially offset by sales growth from Byram.

Cost of goods sold.



	Three Months Ended March 31,				Change
(Dollars in thousands)	2019		2018		$		%
Cost of goods sold	$	2,102,964	$	2,047,892	$	55,072	2.7	%

Cost of goods sold includes the cost of the product (net of supplier incentives and cash discounts) and all costs incurred for shipments of products from manufacturers to our distribution centers for all customer arrangements where we are the primary obligor and bear risk of general and physical inventory loss. These are sometimes referred to as distribution or buy/sell contracts. Cost of goods sold also includes direct and certain indirect labor, material and overhead costs associated with our Global Products business. There is no cost of goods sold associated with our fee-for-service arrangements. Cost of goods sold compared to prior year reflects changes in sales activity, including sales mix.

Gross margin.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2019			2018			$		%
Gross margin	$	358,424		$	324,687		$	33,737	10.4	%
As a % of net revenue	14.56		%	13.68		%

Gross margin in the first quarter of 2019 included contributions from Halyard, strong revenue growth with Byram, and increased fee-for-service revenues, which were partially offset by the impact from lower distribution revenues, a decline in distribution margins, and unfavorable impact from foreign currency translation of $6.6 million.

Table of Contents

Operating expenses.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2019			2018			$			%
Distribution, selling and administrative expenses	$	338,703		$	284,361		$	54,342		19.1	%
As a % of net revenue	13.76		%	11.99		%
Other operating expense, net	$	39		$	1,349		$	(1,310	)	(97.1	)%

Distribution, selling and administrative (DS&A) expenses include labor and warehousing costs associated with our distribution and logistics services and all costs associated with our fee-for-service arrangements. Shipping and handling costs are primarily included in DS&A expenses and include costs to store, move, and prepare products for shipment, as well as costs to deliver products to customers.

Overall DS&A expenses compared to prior year reflected increased expenses related to expenses to support the Halyard business, strong revenue growth with Byram, and fee-for-service arrangements within Manufacturer Solutions, higher transportation fleet costs and delivery expenses, and increased expenses incurred for the development of new customer solutions, partially offset by favorable impacts for foreign currency translation of $6.6 million.

The decrease in other operating expense, net was attributed primarily to lower software as a service implementation expenses.

A discussion of the acquisition-related and exit and realignment charges is included above in the Overview section.

Interest expense, net.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2019			2018			$		%
Interest expense, net	$	29,101		$	10,253		$	18,848	183.8	%
Effective interest rate	6.34		%	4.52		%

Interest expense in the first quarter of 2019 was higher than prior year primarily as a result of borrowings under our revolving credit facility and term loans entered into in the second quarter of 2018. In addition, interest expense included $2.0 million related to write-off of deferred financing costs associated with the revolving credit facility as a result of the debt amendment in February 2019. See Note 10 in Notes to Consolidated Financial Statements.

Income taxes.



	Three Months Ended March 31,						Change
(Dollars in thousands)	2019			2018			$			%
Income tax provision	$	(313	)	$	5,813		$	(6,126	)	(105.4	)%
Effective tax rate	2.2		%	41.6		%

The effective tax rate was 2.2% for the quarter ended March 31, 2019, compared to 41.6% in the same quarter of 2018. The decrease in the rate resulted from the mixture of income and losses in jurisdictions in which the Company operates, including those of which require a full valuation allowance, and the incremental income tax expense associated with the vesting of restricted stock.

Table of Contents

Financial Condition, Liquidity and Capital Resources

Financial condition. We monitor operating working capital through days sales outstanding (DSO) and merchandise inventory turnover. We estimate a hypothetical increase (decrease) in DSO of one day would result in a decrease (increase) in our cash balances, an increase (decrease) in borrowings against our revolving credit facility, or a combination thereof of approximately $27 million.

The majority of our cash and cash equivalents are held in cash depository accounts with major banks in the United States, Europe, and Asia. Changes in our working capital can vary in the normal course of business based upon the timing of inventory purchases, collection of accounts receivable, and payment to suppliers.



	March 31, 2019		December 31, 2018		Change
(Dollars in thousands)	March 31, 2019		December 31, 2018		$			%
Cash and cash equivalents	$	75,239	$	103,367	$	(28,128	)	(27.2	)%
Accounts receivable, net of allowances	$	843,384	$	823,418	$	19,966		2.4	%
Consolidated DSO ⁽¹⁾	29.4		28.5
Merchandise inventories	$	1,210,558	$	1,290,103	$	(79,545	)	(6.2	)%
Consolidated inventory turnover ⁽²⁾	6.8		7.4
Accounts payable	$	990,688	$	1,109,589	$	(118,901	)	(10.7	)%

(1) Based on period end accounts receivable and net revenue for the quarter

(2) Based on average annual inventory and costs of goods sold for the quarter ended March 31, 2019 and year ended December 31, 2018

Liquidity and capital expenditures. The following table summarizes our consolidated statements of cash flows for the three months ended March 31, 2019 and 2018:



(Dollars in thousands)	2019			2018
Net cash provided by (used for):
Operating activities	$	(60,904	)	$	18,273
Investing activities	(14,008		)	(14,160		)
Financing activities	49,505			(21,803		)
Effect of exchange rate changes	(2,721		)	800
Increase (decrease) in cash and cash equivalents	$	(28,128	)	$	(16,890	)

Cash used for (provided by) operating activities in the first three months of 2019 reflected fluctuations in net income along with changes in working capital.

Cash used for investing activities in the first three months of 2019 included capital expenditures of $14.3 million for our strategic and operational efficiency initiatives, particularly initiatives relating to capital expenditures of property and equipment and capitalized software.

Cash provided by (used for) financing activities included dividend payments of $4.8 million in the first three months of 2019, compared to $16.1 million in the same period of 2018. In the first quarter of 2019 and 2018, cash provided by (used for) financing activities included proceeds from borrowings of $72.1 million and $(0.3) million under our revolving credit facility. Financing activities in the first quarter of 2019 and 2018 also included the repayment of $12.4 million and $3.1 million in borrowings on our Credit Agreement. The Company also paid $4.3 million in financing costs related to the Fourth Amendment to the Credit Agreement in February 2019.

Capital resources. Our sources of liquidity include cash and cash equivalents and a revolving credit facility under our Credit Agreement (amended February 2019) with Wells Fargo Bank, N.A., JPMorgan Chase Bank, N.A., Bank of America, N.A. and a syndicate of financial institutions (the Credit Agreement). The Credit Agreement provides a borrowing capacity of $400 million and $914 million outstanding in term loans. The interest rate on our revolving credit facility and Term A loans is based on the Eurocurrency Rate, the Federal Funds Rate or the Prime Rate, plus an adjustment based on our Consolidated Total Leverage Ratio as defined by the Credit Agreement. Our Term B loan accrues interest based on the Eurocurrency Rate, the Federal Funds Rate or the Prime Rate, plus interest rate margin of 3.50% per annum with respect to Base Rate Loans (as defined in the Credit Agreement), and 4.50% per annum with respect to Eurocurrency Rate Loans (as defined in the Credit Agreement). We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Credit Agreement requires us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. Our credit spread at March 31, 2019 was Eurocurrency Rate plus 3.5%.

Table of Contents

At March 31, 2019, we had borrowings of $282.2 million under the revolver and letters of credit of $11.7 million outstanding under the Credit Agreement along with $550 million in Senior Notes. We also had letters of credit and bank guarantees outstanding for $7.7 million as of March 31, 2019 and December 31, 2018, which supports certain facilities leased as well as other normal business activities in the United States and Europe.

The fourth quarter dividend of $0.075 per share was accrued at December 31, 2018 and paid in January 2019. The first quarter dividend of $0.0025 per share was paid in March 2019. The payment of future dividends remains within the discretion of the Board of Directors and will depend upon our results of operations, financial condition, capital requirements, current and future limitations under our Credit Agreement (as amended) and other factors.

Our Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in December 2019. The program is intended to offset shares issued in conjunction with our stock incentive plan and return capital to shareholders, and may be suspended or discontinued at any time. However, our Credit Agreement contains restrictions on the amount and timing of share repurchase activity. This includes prohibiting share repurchases should a default under the Credit Agreement exist prior to or immediately after any share repurchases. We did not repurchase any shares during 2019. At March 31, 2019, the remaining amount authorized for repurchase under this program was $94.0 million.

We believe available financing sources, including cash generated by operating activities and borrowings under the Credit Agreement, will be sufficient to fund our working capital needs, capital expenditures, long-term strategic growth, payments under long-term debt and lease arrangements, payments of quarterly cash dividends, share repurchases and other cash requirements. While we believe that we will have the ability to meet our financing needs in the foreseeable future, changes in economic conditions may impact (i) the ability of financial institutions to meet their contractual commitments to us, (ii) the ability of our customers and suppliers to meet their obligations to us or (iii) our cost of borrowing.

We earn a portion of our operating income in foreign jurisdictions outside the United States. Prior to the reporting period in which the Tax Cuts and Jobs Act (the Act) was enacted we considered foreign earnings to be indefinitely reinvested and provided no United States federal and state taxes or withholding taxes on those earnings. Our cash and cash equivalents held by our foreign subsidiaries totaled $61.2 million at March 31, 2019 and $64.9 million at December 31, 2018. Upon enactment, the Act imposes a tax on our total post-1986 foreign earnings at various tax rates. The Company has recognized an amount for this one-time transition tax. The Company continues to remain permanently reinvested in its foreign subsidiaries, with the exception of our newly acquired subsidiary in Thailand. No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax, or any additional outside basis difference inherent in these entities in which we assert permanent reinvestment. Management has no specific plans to indefinitely reinvest the unremitted earnings of our newly acquired foreign subsidiary located in Thailand as of March 31, 2019. As such, we have recorded withholding tax liabilities that would be incurred upon future distribution to the U.S. There are no unrecognized deferred taxes as there is no outside basis difference unrelated to unremitted earnings for Thailand. The Company will continue to evaluate its foreign earnings repatriation policy during 2019 for all other foreign subsidiaries in which we operate.

Table of Contents

Recent Accounting Pronouncements

For a discussion of recent accounting pronouncements, see our Annual Report on Form 10-K for the year ended December 31, 2018 and Note 17 in the Notes to Consolidated Financial Statements, included in this Quarterly Report on Form 10-Q for the quarterly period ended on March 31, 2019.

Forward-looking Statements

Certain statements in this discussion constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Although we believe our expectations with respect to the forward-looking statements are based upon reasonable assumptions within the bounds of our knowledge of our business and operations, all forward-looking statements involve risks and uncertainties and, as a result, actual results could differ materially from those projected, anticipated or implied by these statements. Such forward-looking statements involve known and unknown risks, including, but not limited to:


•	competitive pressures in the marketplace, including intense pricing pressure;


•	our ability to retain existing and attract new customers in a market characterized by significant customer consolidation and intense cost-containment initiatives;


•	our dependence on sales to certain customers or the loss or material reduction in purchases by key customers;


•	our dependence on distribution of product of certain suppliers;


•	our ability to successfully identify, manage or integrate acquisitions, including our ability to successfully integrate the S&IP business into our operations and to realize the anticipated benefits and synergies from the S&IP acquisition;


•	our ability to successfully manage our international operations, including risks associated with changes in international trade regulations, foreign currency volatility, changes in regulatory conditions, deteriorating economic conditions, adverse tax consequences, and other risks of operating in international markets;


•	uncertainties related to and our ability to adapt to changes in government regulations, including healthcare laws and regulations (including the Affordable Care Act);


•	risks arising from possible violations of legal, regulatory or licensing requirements of the markets in which we operate;


•	uncertainties related to general economic, regulatory and business conditions;


•	our ability to successfully implement our strategic initiatives;


•	the availability of and modifications to existing supplier funding programs and our ability to meet the terms to qualify for certain of these programs;


•	the effect of price volatility in the commodities markets, including fuel price fluctuations, on our operating costs and supplier product prices;


•	our ability to adapt to changes in product pricing and other terms of purchase by suppliers of product;


•	the ability of customers and suppliers to meet financial commitments due to us;


•	changes in manufacturer preferences between direct sales and wholesale distribution;


•	changing trends in customer profiles and ordering patterns and our ability to meet customer demand for additional value-added services;


•	our ability to manage operating expenses and improve operational efficiencies in response to changing customer profiles;


•	our ability to meet performance targets specified by customer contracts under contractual commitments;


•	availability of and our ability to access special inventory buying opportunities;


•	the ability of business partners and financial institutions to perform their contractual responsibilities;


•	our ability to continue to obtain financing at reasonable rates and to manage financing costs and interest rate risk;


•	the risk that information systems are interrupted or damaged or fail for any extended period of time, that new information systems are not successfully implemented or integrated, or that there is a data security breach in our information systems;

Table of Contents


•	the risk that a decline in business volume or profitability could result in an impairment of goodwill or other long-lived assets;


•	our ability to timely or adequately respond to technological advances in the medical supply industry;


•	the costs associated with and outcome of outstanding and any future litigation, including product and professional liability claims;


•	adverse changes in U.S. and foreign tax laws and the outcome of outstanding tax contingencies and legislative and tax proposals;


•	our ability to successfully implement the expense reduction and productivity and efficiency increasing initiatives;


•	our ability to continue to comply with the terms and conditions of Byram Healthcare’s Corporate Integrity Agreement;


•	the potentially adverse impact of the United Kingdom’s planned withdrawal from the European Union; and


•	other factors detailed from time to time in the reports we file with the SEC.

We undertake no obligation to update or revise any forward-looking statements, except as required by applicable law.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in interest rates related to our borrowing under our Credit Agreement. However, we enter into interest rate swap agreements to manage our exposure to interest rate changes. We had $914 million in borrowings under our term loans, $282 million in borrowings under our revolving credit facility and $12 million in letters of credit under the Credit Agreement at March 31, 2019. After considering the effects of interest rate swap agreements entered into during July 2018, we estimate an increase in interest rates of 100 basis points would result in a potential reduction in future pre-tax earnings of approximately $7 million per year based on our borrowings outstanding and the effective interest rates at March 31, 2019.

Due to the nature and pricing of our Global Solutions segment distribution services, we are exposed to potential volatility in fuel prices. Our strategies for helping to mitigate our exposure to changing domestic fuel prices have included using trucks with improved fuel efficiency. We benchmark our domestic diesel fuel purchase prices against the U.S. Weekly Retail On-Highway Diesel Prices (benchmark) as quoted by the U.S. Energy Information Administration. The benchmark averaged $3.02 per gallon in the first three months of 2019 and 2018. Based on our fuel consumption in the first three months of 2019, we estimate that every 10 cents per gallon increase in the benchmark would reduce our Global Solutions segment operating income by approximately $0.4 million on an annualized basis.

In the normal course of business, we are exposed to foreign currency translation and transaction risks. Our business transactions outside of the United States are primarily denominated in the euro, British pound and Thai baht. We may use foreign currency forwards, swaps and options, where possible, to manage our risk related to certain foreign currency fluctuations.

We are subject to price risk for our raw materials, the most significant of which relates to the cost of polypropylene and nitrile used in the manufacturing processes of our Global Products segment. Prices of the commodities underlying these raw materials are volatile and have fluctuated significantly in recent years and in the future may contribute to fluctuations in our results of operations. The ability to hedge these commodity prices is limited.

Item 4. Controls and Procedures

We carried out an evaluation, with the participation of management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (pursuant to Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, the principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2019.

In connection with the Halyard acquisition, we entered into transition services agreements with Avanos pursuant to which they and we will provide to each other various transitional services, including, but not limited to, facilities, product supply, financial and business services, procurement, human resources, regulatory affairs and quality assurance, sales and marketing, information technology and other support services for a period of up to 18 months after the closing date. Management has established controls to mitigate the risk over financial reporting and will continue to monitor and evaluate the sufficiency of the controls. We are currently evaluating the acquired processes, information technology systems and other components of internal controls over financial reporting as part of the Company's integration activities which may result in periodic changes. Such changes will be disclosed as required by applicable SEC guidance.

Table of Contents

In the second quarter of 2018, we acquired the Halyard Surgical & Infection Prevention business. This acquisition represented $682 million of total assets and $189 million of revenues (net of intercompany eliminations) as of and for the three months ended March 31, 2019. Management's evaluation and conclusion as to the effectiveness of the design and operation of the Company's disclosure controls and procedures as of and for the period covered by this report excludes any evaluation of the internal control over financial reporting of this acquisition.

There was no change in our internal control over financial reporting that occurred during the period of this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. We implemented internal controls to ensure we adequately assessed the adoption impact of the new lease standard, and its related amendments, on our consolidated financial statements. There were no significant changes to our internal control over financial reporting due to the adoption of the new standard.

Part II. Other Information

Item 1. Legal Proceedings

Certain legal proceedings pending against us are described in our Annual Report on Form 10-K for the year ended December 31, 2018. Through March 31, 2019, there have been no material developments in any legal proceedings reported in such Annual Report.

Item 1A. Risk Factors

Certain risk factors that we believe could affect our business and prospects are described in our Annual Report on Form 10-K for the year ended December 31, 2018. Through March 31, 2019, there have been no material changes in the risk factors described in such Annual Report.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

In October 2016, our Board of Directors authorized a share repurchase program of up to $100 million of the company’s outstanding common stock to be executed at the discretion of management over a three-year period. The timing of repurchases and the exact number of shares of common stock to be purchased will depend upon market conditions and other factors and may be suspended or discontinued at any time. Purchases under the share repurchase program are made either pursuant to 10b5-1 plans entered into by the company from time to time and/or during the company’s scheduled quarterly trading windows for officers and directors. We did not repurchase any shares for the three months ended March 31, 2019.

Table of Contents

Item 6. Exhibits


(a)	Exhibits




31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

		* Certain exhibits and schedules been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish copies of such omitted materials supplementally upon request by the SEC.
		** Management contract or compensatory plan or arrangement

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



		Owens & Minor, Inc.
		(Registrant)

Date:	May 7, 2019	/s/ Edward A. Pesicka
		Edward A. Pesicka
		President & Chief Executive Officer

Date:	May 7, 2019	/s/ Robert K. Snead
		Robert K. Snead
		Executive Vice President & Chief Financial Officer